Sofwave Medical Ltd
TASE:SOFW
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 196
2 021
|
| Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sofwave Medical Ltd
Total Liabilities & Equity
Sofwave Medical Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Total Liabilities & Equity
$43.5m
|
CAGR 3-Years
108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
Total Liabilities & Equity
$218.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
158%
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Total Liabilities & Equity
$63m
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Total Liabilities & Equity
$824m
|
CAGR 3-Years
23%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Sisram Medical Ltd
HKEX:1696
|
Total Liabilities & Equity
$626.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
Total Liabilities & Equity
$40.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sofwave Medical Ltd
Glance View
Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.
See Also
What is Sofwave Medical Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
43.5m
USD
Based on the financial report for Dec 31, 2023, Sofwave Medical Ltd's Total Liabilities & Equity amounts to 43.5m USD.
What is Sofwave Medical Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
108%
Over the last year, the Total Liabilities & Equity growth was -6%. The average annual Total Liabilities & Equity growth rates for Sofwave Medical Ltd have been 108% over the past three years .
You don't have any saved screeners yet
